Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    A Pilot, Predictive Surveillance Model in Pharmacovigilance Using Machine Learning Approaches

    The identification of a new adverse event (AE) caused by a drug product is one of the key activities in the pharmaceutical industry to ensure the safety profile of a drug product. Machine learning (ML) has the...

    Rosa De Abreu Ferreira, Sheng Zhong, Charlotte Moureaud in Advances in Therapy (2024)

  2. No Access

    Article

    Study Protocol of a Randomized Controlled Clinical Trial to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in COVID-19 Patients with Comorbidities

    Ropeginterferon alfa-2b represents a new-generation PEGylated interferon. It is approved for the treatment of polycythemia vera and shows promising anti-SARS-CoV-2 activities.

    Wang-Da Liu, Hsin-An Hou, Ko-Jen Li, Albert Qin, Chan-Yen Tsai in Advances in Therapy (2024)

  3. Article

    Open Access

    Dosing Patterns of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab in the United States: A Retrospective Claims-Based Analysis

    Complement factor 5 inhibitors eculizumab and, recently, ravulizumab are standard therapies for paroxysmal nocturnal hemoglobinuria (PNH). However, some patients experience suboptimal response and may benefit ...

    Wendy Y. Cheng, Jesse Fishman, Mihran Yenikomshian, Malena Mahendran in Advances in Therapy (2024)

  4. Article

    Open Access

    Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison

    Raymond Wong, Jesse Fishman, Koo Wilson, Michael Yeh in Advances in Therapy (2023)

  5. No Access

    Article

    Genetic Evidence Supporting a Causal Association Between mTOR-Dependent EIF-4E Circulating Protein Level and Osteoporosis

    The mechanistic target of rapamycin (mTOR) regulates bone homeostasis, a crucial factor in osteoporosis (OP) development. However, most research is based on observational studies, and the causality remains unc...

    Ting Cheng, Yao-Chen Zhang, Ke-Yi Fan, **g-** Hu, Qian Wang in Advances in Therapy (2023)

  6. Article

    Open Access

    A Phase 1 Multiple Dose Study of Tirzepatide in Chinese Patients with Type 2 Diabetes

    To investigate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of tirzepatide in Chinese patients with type 2 diabetes (T2D).

    ** Feng, **aoyan Sheng, Yongjia Ji, Shweta Urva, Feng Wang in Advances in Therapy (2023)

  7. No Access

    Article

    Significance of Dynamic Changes of VCA-IgA Levels in Pre- and Post-treatment Plasma of Patients with Nasopharyngeal Carcinoma: Development of a Clinically-Oriented Model

    Nasopharyngeal carcinoma (NPC) responds well to radiotherapy but recurrence and metastasis are common. Currently, there is no widely used biomarker for accurately predicting the recurrence and metastasis of NP...

    Minjie Mao, Hui Sheng, Boyu Tian, Peidong Chi, Kewei Huang in Advances in Therapy (2023)

  8. Article

    Open Access

    Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials

    Emerging evidence suggests psoriatic arthritis (PsA) with axial involvement (axPsA) and radiographic axial spondyloarthritis (r-axSpA) may possibly represent distinct disorders, with some differing clinical ma...

    Arthur Kavanaugh, Xenofon Baraliakos, Sheng Gao, Warner Chen in Advances in Therapy (2023)

  9. No Access

    Article

    Genetic Evidence Supporting Causal Roles of mTOR-Dependent Proteins in Rheumatic Fever: A Two-Sample Randomized Mendelian Study

    The expression of signaling molecules downstream of the mammalian target of rapamycin (mTOR) is dysregulated in patients with rheumatic fever (RF), but the causality of mTOR on RF remains unknown. This study a...

    Yan-Fei Mu, Qian Wang, **g-** Hu, Qi Wang, Yao-Chen Zhang in Advances in Therapy (2023)

  10. Article

    Open Access

    Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison

    In the absence of head-to-head trials, this study compared treatment outcomes with the C3 complement inhibitor pegcetacoplan versus the C5 complement inhibitor eculizumab or ravulizumab in complement inhibitor...

    Raymond Wong, Jesse Fishman, Koo Wilson, Michael Yeh in Advances in Therapy (2023)

  11. No Access

    Article

    Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid Arthritis

    CMAB008 is a monoclonal antibody developed as a biosimilar to infliximab (Remicade®, Janssen). The pharmacokinetic characteristics of CMAB008 and Remicade® in healthy subjects and patients with moderately to seve...

    Yin Su, **g Li, Chenguang Wang, Xunmin Zhang, Sheng Hou, Huaizu Guo in Advances in Therapy (2023)

  12. Article

    Open Access

    Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database Study

    The prevalence of chronic hepatitis B virus (HBV) infection is high in many countries; however, robust, real-world epidemiological data are lacking. This study describes the prevalence, characteristics, treatm...

    Iain A. Gillespie, K. Arnold Chan, Yunhao Liu, Shu-Feng Hsieh in Advances in Therapy (2023)

  13. No Access

    Article

    Peripheral Treg Levels and Transforming Growth Factor-β (TGFβ) in Patients with Psoriatic Arthritis: A Systematic Review Meta-Analysis

    Studies on the level of regulatory T (Treg) cells in psoriatic arthritis (PsA) have been controversial, leading to disagreement regarding the role Treg cells play in the pathogenesis of the disease. To clarify th...

    Qin-Yi Su, Sheng-**ao Zhang, Liu Yang, **g Luo, **ao-Feng Li in Advances in Therapy (2023)

  14. No Access

    Article

    Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer

    A high malignancy rate and poor prognosis are common problems with triple-negative breast cancer (TNBC). There is increasing evidence that glycolysis plays vital roles in tumorigenesis, tumor invasion, immune...

    Jian Zheng, Yi-Fan Zhang, Guo-Hui Han, Meng-Ying Fan, Ming-Hui Du in Advances in Therapy (2023)

  15. No Access

    Article

    Levels of Peripheral Th17 Cells and Th17-Related Cytokines in Patients with Ankylosing Spondylitis: A Meta-analysis

    Ankylosing spondylitis (AS) is a chronic inflammatory disease. Several proinflammatory cytokines produced by T helper 17 (Th17) cells are involved in the pathogenesis of AS. We performed a meta-analysis to det...

    Qin-Yi Su, **g-Wen Zheng, **g-Yuan Yang, Tong-Yuan Zhang in Advances in Therapy (2022)

  16. Article

    Open Access

    Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis

    Atopic dermatitis (AD) is associated with significant quality-of-life and economic burdens. Real-world evidence is needed to identify optimal treatment pathways for AD. Here we evaluate real-world effectivenes...

    Jashin J. Wu, Marie-Hélène Lafeuille, Bruno Emond, Iman Fakih in Advances in Therapy (2022)

  17. No Access

    Article

    Cost-Effectiveness of Donafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma in China

    This study aimed to evaluate the cost-effectiveness of donafenib compared to sorafenib and lenvatinib as first-line treatments for patients with advanced hepatocellular carcinoma (HCC) in China.

    Hai**g Guan, Chun** Wang, Zhigang Zhao, Sheng Han in Advances in Therapy (2022)

  18. Article

    Open Access

    Literature Review of Fatigue Scales and Association with Clinically Meaningful Improvements in Outcomes Among Patients With and Without Paroxysmal Nocturnal Hemoglobinuria

    Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder characterized by anemia and debilitating fatigue. Limited evidence characterizes the association between hemoglobin, an indicator of anemia an...

    Sangeeta Krishnan, Sujata Sarda, Colin Kunzweiler, Melody Wu in Advances in Therapy (2022)

  19. Article

    Open Access

    Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population

    Approximately 30% of patients with a first acute pericarditis episode experience a recurrence ≤ 18 months; ~ 15% experience multiple recurrences. This study assessed the recurrence and economic burden among pa...

    David Lin, François Laliberté, Christine Majeski, Matt Magestro in Advances in Therapy (2021)

  20. Article

    Open Access

    Cost-Effectiveness of Vedolizumab in the Treatment of Moderate-to-Severe Crohn’s Disease in China

    To compare the cost-effectiveness of vedolizumab with that of conventional therapy in patients with moderate-to-severe active Crohn’s disease (CD) in China.

    Ting Zhou, Yanan Sheng, Hai**g Guan in Advances in Therapy (2021)

previous disabled Page of 3